Drug Shortage Report for MEZERA
Report ID | 68995 |
Drug Identification Number | 02474026 |
Brand name | MEZERA |
Common or Proper name | Mezera Foam |
Company Name | AVIR PHARMA INC. |
Market Status | MARKETED |
Active Ingredient(s) | MESALAZINE |
Strength(s) | 1G |
Dosage form(s) | FOAM |
Route of administration | RECTAL |
Packaging size | 1g |
ATC code | A07EC |
ATC description | INTESTINALANTIINFLAMMATORY AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-12-10 |
Actual start date | 2018-12-10 |
Estimated end date | 2019-03-01 |
Actual end date | 2019-03-26 |
Shortage status | Resolved |
Updated date | 2019-03-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 660 BOULEVARD INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2019-03-27 | English | Compare |
v6 | 2019-03-26 | French | Compare |
v5 | 2019-03-26 | English | Compare |
v4 | 2018-12-11 | English | Compare |
v3 | 2018-12-10 | French | Compare |
v2 | 2018-12-10 | English | Compare |
v1 | 2018-12-10 | English | Compare |
Showing 1 to 7 of 7